相关实验视频

Updated: Jan 6, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

对SARS-CoV-2的抑制剂开发的可行性:药物设计的系统方法

Guangzhou Sun¹, Quanshan Shi¹, Yuting Song²

¹Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China.

Journal of molecular modeling

|November 28, 2025

概括

奎尔赛丁通过抑制SARS-CoV-2主要蛋白酶 (Mpro) 显示出作为COVID-19治疗的潜力. 这种天然化合物为现有药物提供了一个有希望的替代品,需要进一步的实验研究.

科学领域:

药物的发现和开发.
计算化学是一种计算化学.
病毒学病毒学

背景情况:

SARS-CoV-2 主蛋白酶 (Mpro) 对于病毒复制至关重要,也是关键的治疗点.
像Paxlovid这样的现有COVID-19治疗方法具有包括副作用和高成本在内的局限性.
需要新的Mpro抑制剂来解决这些局限性并改善患者的治疗结果.

研究的目的:

使用虚拟查识别SARS-CoV-2主要蛋白酶 (Mpro) 的新型抑制剂.
通过分子动力学模拟来评估已识别的抑制剂的结合机制和疗效.
建立一个计算药物查管道,用于识别潜在的COVID-19治疗方法.

主要方法:

建立一个药物和食品同类植物药物 (MF-HHD) 数据库.
多个阶段的虚拟查,包括基于联体的药,基于Vina的药和形成药物的查.
500 ns的分子动力学模拟,自由能景观和构造集群分析.

主要成果:

奎尔赛丁被确定为SARS-CoV-2 Mpro. 的强有力的抑制剂.
分子动力学揭示了氨酸的结合机制,稳定了Mpro并改变了其活性口袋相互作用.
氨酸结合诱导了Mpro的显著构造变化,影响了其功能.

结论:

奎尔是针对SARS-CoV-2 Mpro.的COVID-19治疗的有希望的候选人.
虚拟查和分子动力学模拟为发现新的抗病毒药物提供了经过验证的方法.
建议对昆塞丁进行进一步的实验评估,以了解其对抗COVID-19的潜在治疗应用.

关键词:

药物查是指对药物进行查.联网网络的联网是联网.主要蛋白质主要蛋白质医学和食品同类学草药数据库数据库这就是SARS-CoV-2病毒.

更多相关视频

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...